ID THOP1_HUMAN Reviewed; 689 AA. AC P52888; B3KSE2; Q9UCB3; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 24-JAN-2024, entry version 207. DE RecName: Full=Thimet oligopeptidase {ECO:0000303|PubMed:17251185}; DE EC=3.4.24.15 {ECO:0000305|PubMed:7639763}; DE AltName: Full=Endopeptidase 24.15 {ECO:0000303|Ref.2}; DE AltName: Full=MP78 {ECO:0000303|PubMed:7639763}; GN Name=THOP1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC ACTIVITY. RC TISSUE=Brain; RX PubMed=7639763; DOI=10.1006/bbrc.1995.2099; RA Thompson A., Huber G., Malherbe P.; RT "Cloning and functional expression of a metalloendopeptidase from human RT brain with the ability to cleave a beta-APP substrate peptide."; RL Biochem. Biophys. Res. Commun. 213:66-73(1995). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Taylor G.R., Otulakowski G., Lau C.Y., Munroe D.G.; RT "cDNA cloning and gene structure of a human gene encoding a highly RT conserved metalloendopeptidase (EC 3.4.24.15)."; RL Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Testis; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Lung, and Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PROTEIN SEQUENCE OF 67-78; 181-197 AND 199-200. RC TISSUE=Brain; RX PubMed=8286339; DOI=10.1021/bi00167a025; RA Papastoitsis G., Siman R., Scott R., Abraham C.R.; RT "Identification of a metalloprotease from Alzheimer's disease brain able to RT degrade the beta-amyloid precursor protein and generate amyloidogenic RT fragments."; RL Biochemistry 33:192-199(1994). RN [7] RP ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-257 AND LYS-538, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19608861; DOI=10.1126/science.1175371; RA Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., RA Olsen J.V., Mann M.; RT "Lysine acetylation targets protein complexes and co-regulates major RT cellular functions."; RL Science 325:834-840(2009). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [9] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [12] RP X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 16-688, ZINC-BINDING SITES, RP COFACTOR, ACTIVE SITE, FUNCTION, AND SUBUNIT. RX PubMed=17251185; DOI=10.1074/jbc.m609897200; RA Lim E.J., Sampath S., Coll-Rodriguez J., Schmidt J., Ray K., Rodgers D.W.; RT "Swapping the substrate specificities of the neuropeptidases neurolysin and RT thimet oligopeptidase."; RL J. Biol. Chem. 282:9722-9732(2007). CC -!- FUNCTION: Involved in the metabolism of neuropeptides under 20 amino CC acid residues long. Involved in cytoplasmic peptide degradation CC (PubMed:7639763, PubMed:17251185). Able to degrade the amyloid-beta CC precursor protein and generate amyloidogenic fragments (PubMed:7639763, CC PubMed:17251185). Also acts as a regulator of cannabinoid signaling CC pathway by mediating degradation of hemopressin, an antagonist peptide CC of the cannabinoid receptor CNR1 (By similarity). CC {ECO:0000250|UniProtKB:P24155, ECO:0000269|PubMed:17251185, CC ECO:0000269|PubMed:7639763}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Preferential cleavage of bonds with hydrophobic residues at CC P1, P2 and P3' and a small residue at P1' in substrates of 5 to 15 CC residues.; EC=3.4.24.15; Evidence={ECO:0000305|PubMed:7639763}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000269|PubMed:17251185}; CC Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:17251185}; CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P47788}. CC -!- INTERACTION: CC P52888; O95208-2: EPN2; NbExp=3; IntAct=EBI-372399, EBI-12135243; CC P52888; Q96CV9: OPTN; NbExp=3; IntAct=EBI-372399, EBI-748974; CC P52888; P62161: Calm3; Xeno; NbExp=2; IntAct=EBI-372399, EBI-397530; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P47788}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P52888-1; Sequence=Displayed; CC Name=2; CC IsoId=P52888-2; Sequence=VSP_056494, VSP_056495; CC -!- SIMILARITY: Belongs to the peptidase M3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z50115; CAA90477.1; -; mRNA. DR EMBL; U29366; AAA82607.1; -; mRNA. DR EMBL; AK093392; BAG52704.1; -; mRNA. DR EMBL; AC006538; AAD13118.1; -; Genomic_DNA. DR EMBL; BC000135; AAH00135.1; -; mRNA. DR EMBL; BC002391; AAH02391.1; -; mRNA. DR CCDS; CCDS12095.1; -. [P52888-1] DR PIR; JC4197; HYHUTH. DR RefSeq; NP_003240.1; NM_003249.4. [P52888-1] DR PDB; 1S4B; X-ray; 2.00 A; P=16-689. DR PDB; 2O36; X-ray; 1.95 A; A=16-688. DR PDBsum; 1S4B; -. DR PDBsum; 2O36; -. DR AlphaFoldDB; P52888; -. DR SMR; P52888; -. DR BioGRID; 112921; 84. DR IntAct; P52888; 13. DR MINT; P52888; -. DR STRING; 9606.ENSP00000304467; -. DR MEROPS; M03.001; -. DR GlyGen; P52888; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P52888; -. DR PhosphoSitePlus; P52888; -. DR SwissPalm; P52888; -. DR BioMuta; THOP1; -. DR DMDM; 1708983; -. DR EPD; P52888; -. DR jPOST; P52888; -. DR MassIVE; P52888; -. DR MaxQB; P52888; -. DR PaxDb; 9606-ENSP00000304467; -. DR PeptideAtlas; P52888; -. DR ProteomicsDB; 3634; -. DR ProteomicsDB; 56547; -. [P52888-1] DR Pumba; P52888; -. DR Antibodypedia; 23054; 277 antibodies from 30 providers. DR DNASU; 7064; -. DR Ensembl; ENST00000307741.11; ENSP00000304467.5; ENSG00000172009.15. [P52888-1] DR Ensembl; ENST00000395212.8; ENSP00000378638.3; ENSG00000172009.15. [P52888-2] DR GeneID; 7064; -. DR KEGG; hsa:7064; -. DR MANE-Select; ENST00000307741.11; ENSP00000304467.5; NM_003249.5; NP_003240.1. DR UCSC; uc002lwj.4; human. [P52888-1] DR AGR; HGNC:11793; -. DR CTD; 7064; -. DR DisGeNET; 7064; -. DR GeneCards; THOP1; -. DR HGNC; HGNC:11793; THOP1. DR HPA; ENSG00000172009; Low tissue specificity. DR MIM; 601117; gene. DR neXtProt; NX_P52888; -. DR OpenTargets; ENSG00000172009; -. DR PharmGKB; PA36505; -. DR VEuPathDB; HostDB:ENSG00000172009; -. DR eggNOG; KOG2089; Eukaryota. DR GeneTree; ENSGT00950000183171; -. DR HOGENOM; CLU_001805_2_0_1; -. DR InParanoid; P52888; -. DR OMA; KNFQSAM; -. DR OrthoDB; 735202at2759; -. DR PhylomeDB; P52888; -. DR TreeFam; TF300459; -. DR BRENDA; 3.4.24.15; 2681. DR PathwayCommons; P52888; -. DR Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR SignaLink; P52888; -. DR SIGNOR; P52888; -. DR BioGRID-ORCS; 7064; 22 hits in 1155 CRISPR screens. DR ChiTaRS; THOP1; human. DR EvolutionaryTrace; P52888; -. DR GeneWiki; THOP1; -. DR GenomeRNAi; 7064; -. DR Pharos; P52888; Tbio. DR PRO; PR:P52888; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; P52888; Protein. DR Bgee; ENSG00000172009; Expressed in left testis and 125 other cell types or tissues. DR ExpressionAtlas; P52888; baseline and differential. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005758; C:mitochondrial intermembrane space; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central. DR GO; GO:0006518; P:peptide metabolic process; IBA:GO_Central. DR GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome. DR GO; GO:0006508; P:proteolysis; IBA:GO_Central. DR CDD; cd06455; M3A_TOP; 1. DR Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1. DR Gene3D; 1.10.1370.10; Neurolysin, domain 3; 1. DR InterPro; IPR024079; MetalloPept_cat_dom_sf. DR InterPro; IPR024077; Neurolysin/TOP_dom2. DR InterPro; IPR024080; Neurolysin/TOP_N. DR InterPro; IPR045090; Pept_M3A_M3B. DR InterPro; IPR001567; Pept_M3A_M3B_dom. DR PANTHER; PTHR11804; PROTEASE M3 THIMET OLIGOPEPTIDASE-RELATED; 1. DR PANTHER; PTHR11804:SF50; THIMET OLIGOPEPTIDASE; 1. DR Pfam; PF01432; Peptidase_M3; 1. DR SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1. DR PROSITE; PS00142; ZINC_PROTEASE; 1. DR Genevisible; P52888; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; Cytoplasm; KW Direct protein sequencing; Hydrolase; Metal-binding; Metalloprotease; KW Phosphoprotein; Protease; Reference proteome; Zinc. FT CHAIN 1..689 FT /note="Thimet oligopeptidase" FT /id="PRO_0000078153" FT ACT_SITE 474 FT /evidence="ECO:0000269|PubMed:17251185" FT BINDING 473 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:17251185" FT BINDING 477 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:17251185" FT BINDING 480 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:17251185" FT MOD_RES 16 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT MOD_RES 172 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q8C1A5" FT MOD_RES 257 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT MOD_RES 278 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q8C1A5" FT MOD_RES 538 FT /note="N6-acetyllysine" FT /evidence="ECO:0007744|PubMed:19608861" FT VAR_SEQ 1..489 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_056494" FT VAR_SEQ 636 FT /note="K -> KFPHYEVRPLRHVSLCLPLTWCDPGSGQPPESLTRNRWLPALRAGPA FT LPGCNIALGSLQ (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_056495" FT HELIX 30..52 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 56..58 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 61..64 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 65..83 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 85..88 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 92..113 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 116..128 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 136..151 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 152..155 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 158..184 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 188..191 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 193..198 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 201..204 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 207..209 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 215..220 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 221..230 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 234..244 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 245..248 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 249..269 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 275..280 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 288..324 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 334..336 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 337..348 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 353..356 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 357..359 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 362..377 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 379..383 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 395..401 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 402..404 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 407..414 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 426..431 FT /evidence="ECO:0007829|PDB:2O36" FT STRAND 444..449 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 465..483 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 489..491 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 498..502 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 503..509 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 510..513 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 515..520 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 525..527 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 533..541 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 542..544 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 547..564 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 572..582 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 594..597 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 599..602 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 606..610 FT /evidence="ECO:0007829|PDB:1S4B" FT HELIX 611..630 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 635..644 FT /evidence="ECO:0007829|PDB:2O36" FT TURN 645..648 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 649..651 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 654..662 FT /evidence="ECO:0007829|PDB:2O36" FT HELIX 669..674 FT /evidence="ECO:0007829|PDB:2O36" SQ SEQUENCE 689 AA; 78840 MW; 092D53DD63B322DE CRC64; MKPPAACAGD MADAASPCSV VNDLRWDLSA QQIEERTREL IEQTKRVYDQ VGTQEFEDVS YESTLKALAD VEVTYTVQRN ILDFPQHVSP SKDIRTASTE ADKKLSEFDV EMSMREDVYQ RIVWLQEKVQ KDSLRPEAAR YLERLIKLGR RNGLHLPRET QENIKRIKKK LSLLCIDFNK NLNEDTTFLP FTLQELGGLP EDFLNSLEKM EDGKLKVTLK YPHYFPLLKK CHVPETRRKV EEAFNCRCKE ENCAILKELV TLRAQKSRLL GFHTHADYVL EMNMAKTSQT VATFLDELAQ KLKPLGEQER AVILELKRAE CERRGLPFDG RIRAWDMRYY MNQVEETRYC VDQNLLKEYF PVQVVTHGLL GIYQELLGLA FHHEEGASAW HEDVRLYTAR DAASGEVVGK FYLDLYPREG KYGHAACFGL QPGCLRQDGS RQIAIAAMVA NFTKPTADAP SLLQHDEVET YFHEFGHVMH QLCSQAEFAM FSGTHVERDF VEAPSQMLEN WVWEQEPLLR MSRHYRTGSA VPRELLEKLI ESRQANTGLF NLRQIVLAKV DQALHTQTDA DPAEEYARLC QEILGVPATP GTNMPATFGH LAGGYDAQYY GYLWSEVYSM DMFHTRFKQE GVLNSKVGMD YRSCILRPGG SEDASAMLRR FLGRDPKQDA FLLSKGLQVG GCEPEPQVC //